Cargando…
The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study
Congestive heart failure (CHF) is the second most prevalent cause of death in rheumatoid arthritis (RA). The systemic inflammatory state in RA patients is deemed responsible for this finding. Anti-inflammatory treatment with anti-tumor necrosis factor (anti-TNF) therapy decreases CV risk and subsequ...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600361/ https://www.ncbi.nlm.nih.gov/pubmed/33003318 http://dx.doi.org/10.3390/jcm9103145 |
_version_ | 1783603125831073792 |
---|---|
author | Baniaamam, Milad Handoko, M. Louis Agca, Rabia Heslinga, Sjoerd C. Konings, Thelma C. van Halm, Vokko P. Nurmohamed, Mike T. |
author_facet | Baniaamam, Milad Handoko, M. Louis Agca, Rabia Heslinga, Sjoerd C. Konings, Thelma C. van Halm, Vokko P. Nurmohamed, Mike T. |
author_sort | Baniaamam, Milad |
collection | PubMed |
description | Congestive heart failure (CHF) is the second most prevalent cause of death in rheumatoid arthritis (RA). The systemic inflammatory state in RA patients is deemed responsible for this finding. Anti-inflammatory treatment with anti-tumor necrosis factor (anti-TNF) therapy decreases CV risk and subsequently might improve the cardiac function by lowering the overall inflammatory state. This study investigated the effect of anti-TNF on the cardiac function in RA patients. Fifty one RA patients were included, of which thirty three completed follow-up. Included patients were >18 years, had moderate–high disease activity and no history of cardiac disease. Patients were assessed at baseline and after six months of anti-TNF treatment. Patients underwent conventional Speckle tracking and tissue Doppler echocardiography in combination with clinical and laboratory assessments at baseline and follow-up. The left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) showed no changes during follow-up, LVEF 63% (±9) to 62% (±8) p = 0.097 and GLS −20 (±4) to −20 (±3) p = 0.79, respectively. Furthermore, E/e’ nor E/A changed significantly between baseline and follow-up, respectively 8 (7–9) and 8 (7–9) p = 0.17 and 1.1 (±0.4) and 1.1 (±0.4) p = 0.94. Follow-up NT-proBNP decreased with 23%, from 89 ng/L (47–142) to 69 ng/L (42–155), p = 0.10. Regression analysis revealed no association between change in inflammatory variables and cardiac function. Echocardiography showed no effect of anti-TNF treatment on the cardiac function in RA patients with low prevalence of cardiac dysfunction. Moreover, NT-proBNP decreased, possibly indicating (subtle) improvement of the cardiac function. |
format | Online Article Text |
id | pubmed-7600361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76003612020-11-01 The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study Baniaamam, Milad Handoko, M. Louis Agca, Rabia Heslinga, Sjoerd C. Konings, Thelma C. van Halm, Vokko P. Nurmohamed, Mike T. J Clin Med Article Congestive heart failure (CHF) is the second most prevalent cause of death in rheumatoid arthritis (RA). The systemic inflammatory state in RA patients is deemed responsible for this finding. Anti-inflammatory treatment with anti-tumor necrosis factor (anti-TNF) therapy decreases CV risk and subsequently might improve the cardiac function by lowering the overall inflammatory state. This study investigated the effect of anti-TNF on the cardiac function in RA patients. Fifty one RA patients were included, of which thirty three completed follow-up. Included patients were >18 years, had moderate–high disease activity and no history of cardiac disease. Patients were assessed at baseline and after six months of anti-TNF treatment. Patients underwent conventional Speckle tracking and tissue Doppler echocardiography in combination with clinical and laboratory assessments at baseline and follow-up. The left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) showed no changes during follow-up, LVEF 63% (±9) to 62% (±8) p = 0.097 and GLS −20 (±4) to −20 (±3) p = 0.79, respectively. Furthermore, E/e’ nor E/A changed significantly between baseline and follow-up, respectively 8 (7–9) and 8 (7–9) p = 0.17 and 1.1 (±0.4) and 1.1 (±0.4) p = 0.94. Follow-up NT-proBNP decreased with 23%, from 89 ng/L (47–142) to 69 ng/L (42–155), p = 0.10. Regression analysis revealed no association between change in inflammatory variables and cardiac function. Echocardiography showed no effect of anti-TNF treatment on the cardiac function in RA patients with low prevalence of cardiac dysfunction. Moreover, NT-proBNP decreased, possibly indicating (subtle) improvement of the cardiac function. MDPI 2020-09-29 /pmc/articles/PMC7600361/ /pubmed/33003318 http://dx.doi.org/10.3390/jcm9103145 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Baniaamam, Milad Handoko, M. Louis Agca, Rabia Heslinga, Sjoerd C. Konings, Thelma C. van Halm, Vokko P. Nurmohamed, Mike T. The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study |
title | The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study |
title_full | The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study |
title_fullStr | The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study |
title_full_unstemmed | The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study |
title_short | The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study |
title_sort | effect of anti-tnf therapy on cardiac function in rheumatoid arthritis: an observational study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600361/ https://www.ncbi.nlm.nih.gov/pubmed/33003318 http://dx.doi.org/10.3390/jcm9103145 |
work_keys_str_mv | AT baniaamammilad theeffectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT handokomlouis theeffectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT agcarabia theeffectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT heslingasjoerdc theeffectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT koningsthelmac theeffectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT vanhalmvokkop theeffectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT nurmohamedmiket theeffectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT baniaamammilad effectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT handokomlouis effectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT agcarabia effectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT heslingasjoerdc effectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT koningsthelmac effectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT vanhalmvokkop effectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy AT nurmohamedmiket effectofantitnftherapyoncardiacfunctioninrheumatoidarthritisanobservationalstudy |